An invited commentary on 'Survival outcomes of neoadjuvant therapy followed by radical resection versus upfront surgery for stage I-III pancreatic ductal adenocarcinoma: a retrospective cohort study'

MeSH terms

• Carcinoma, Pancreatic Ductal* / drug therapy
• Carcinoma, Pancreatic Ductal* / surgery
• Humans
• Neoadjuvant Therapy
• Pancreatectomy
• Pancreatic Neoplasms* / drug therapy
• Pancreatic Neoplasms* / surgery
• Retrospective Studies
• Survival Rate